Open Access Article
This Open Access Article is licensed under a
Creative Commons Attribution 3.0 Unported Licence

Removal of expression of concern: A hypoxia-dissociable siRNA nanoplatform for synergistically enhanced chemo-radiotherapy of glioblastoma

Yandong Xie a, Xueying Lu b, Zhen Wang a, Mingxi Liu a, Liang Liu a, Ran Wang a, Kun Yang a, Hong Xiao c, Jianyong Li *b, Xianglong Tang *ac and Hongyi Liu *a
aDepartment of Neurosurgery, Affiliated Nanjing Brain Hospital, Nanjing Medical University, Nanjing 210029, China. E-mail: hyliu18@njmu.edu.cn; xltang0326@163.com
bDepartment of Hematology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing Medical University, Nanjing 210029, China. E-mail: lijianyonglm@126.com
cDepartment of Neuro-Psychiatric Institute, Affiliated Nanjing Brain Hospital, Nanjing Medical University, Nanjing 210029, China

Received 30th April 2025 , Accepted 30th April 2025

First published on 20th May 2025


Abstract

Removal of expression of concern for ‘A hypoxia-dissociable siRNA nanoplatform for synergistically enhanced chemo-radiotherapy of glioblastoma’ by Yandong Xie et al., Biomater. Sci., 2022, 10, 6791–6803, https://doi.org/10.1039/D2BM01145J.


Biomaterials Science is publishing this removal of expression of concern in order to alert readers that the previous concerns have been addressed.

Nanjing Brain Hospital has investigated the original experimental data and scientific records related to this article. They have confirmed that there is no evidence of fabrication or misconduct and that the data in Fig. 5 is accurate and the conclusions of this paper are valid.

This notice supersedes the information provided in the expression of concern related to this article.

 

Maria Southall

30th April 2025

Executive Editor, Biomaterials Science


This journal is © The Royal Society of Chemistry 2025
Click here to see how this site uses Cookies. View our privacy policy here.